# Effect of New Oral Anticoagulants Dabigatran and Rivaroxaban on Point of Care Coagulation Testing - an Ex-Vivo Study

> **NCT01704053** · — · COMPLETED · sponsor: **Johann Wolfgang Goethe University Hospital** · enrollment: 34 (actual)

## Conditions studied

- Clot Formation and Platelet Aggregation in Point of Care Testing

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01704053
- **Lead sponsor:** Johann Wolfgang Goethe University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2014-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01704053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01704053, "Effect of New Oral Anticoagulants Dabigatran and Rivaroxaban on Point of Care Coagulation Testing - an Ex-Vivo Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01704053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*